drugset / Trial / NCT00586066

Memantine and Cognitive Dysfunction in Bipolar Disorder

NCT00586066

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see whether memantine improves memory function in participants with bipolar disorder who have minimal symptoms. Secondary analyses will test the role of memantine in improving residual mood symptoms (depression and mania) in participants with bipolar disorder. We hypothesize that in participants with bipolar disorder who have minimal symptoms memantine will be effective in improving cognitive functions, as measured by the difference in neuropsychological test scores at the beginning and at the end of the trial.

Timeline

Start
2005-11
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 10 mg

Indications